Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2008
08/13/2008CN101239048A Cyclosporine A fast release solid dosage forms and preparation thereof
08/13/2008CN101239036A Novel pharmaceutical composition containing the ACE inhibitor ramipril and a dihydropyridine compound
08/13/2008CN100410388C Method for identifying compound of increasing bone mineral substance density
08/13/2008CN100410375C Motilin homologs
08/13/2008CN100410276C Polypeptide
08/13/2008CN100410273C Cancer-suppressing protein and its gene and uses
08/13/2008CN100409898C Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody
08/13/2008CN100409896C Senile dementia vaccinum and preparing method thereof
08/13/2008CN100409895C Improved antitumoral treatments
08/13/2008CN100409841C Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration
08/12/2008US7411055 Genetic engineering
08/12/2008US7411054 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
08/12/2008US7411052 Of given sequence; expression vectors; used for inducing differentiation and treatment of leukemia, hemophilia and Alzheimer's disease
08/12/2008US7411050 Bioassay for detection of receptor activated nuclear factor kappa beta ligand (RANKL); identifying modulator immune and inflammatory response
08/12/2008US7411047 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
08/12/2008US7411045 Autocrine growth factor receptor antibodies and methods
08/12/2008US7411044 Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing
08/12/2008US7411042 Immunogenic polypeptide of given sequence; diagnosis or treatment of conditions resulting from gene over-expression
08/12/2008US7411041 DCRS5 polypeptides
08/12/2008US7411040 PRO6182 polypeptides
08/12/2008US7411039 exerts a trophic effects on the small and large intestine via stimulation of cell proliferation and inhibition of apoptosis
08/12/2008US7411038 Synthetic erythrocytes comprising hemoglobin encapsulated in thin filmed core for use in treatment of blood disorders
08/12/2008US7411000 Process of inhibiting cell death in injured cartilage
08/12/2008US7410979 Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections
08/12/2008US7410962 Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
08/12/2008US7410954 Adenovirus serotype 30 (Ad30)
08/12/2008US7410953 Anticancer agent
08/12/2008US7410951 derivatives of Hemiasterlin or Geodiamolide G; pyrido(3,4-B)indole amides; extraction from marine sponges; anti-mitotic and carcinogenic agent; cause mitotic arrest and produce abnormal mitotic spindles
08/12/2008US7410950 Peptides of CaV2.2 that inhibit pain
08/12/2008US7410949 Genetically engineered truncated analogs of significantly lower-molecular-weight and having equal or better potency, pharmacokinetic properties and pharmacological properties as existing Y2R agonists; also pegylated analogs; treating obesity; dietetics; metabolic disorders
08/12/2008US7410948 Analogs of parathyroid hormone
08/12/2008US7410947 Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
08/12/2008US7410946 Method for treating damage in intact skin comprising administering a composition comprising basic milk growth factors in amounts higher than those in milk
08/12/2008US7410945 Treatment of inflammatory bowel disease
08/12/2008US7410943 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma
08/12/2008US7410941 Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin
08/12/2008US7410806 Screening for agents that inhibit complex formation using competitive binding assay based on fluorescence depolarization or internal energy transfer; antiinflammatory
08/12/2008US7410799 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
08/12/2008US7410785 Polypeptide encoded by nucleic acid of given sequence; Glycerol-3-phosphate; modulators of cellular metabolism, energy homeostasis, signal transduction and cell proliferation
08/12/2008US7410780 IL-21 antagonists
08/12/2008US7410779 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
08/12/2008US7410777 Continously induced g-protein coupled receptors; membrane binding assays
08/12/2008US7410776 Novel ligand polypeptide for the orphan G protein-coupled receptor protein, APJ and a DNA encoding the same; use treating HIV infection, cancer, and various other diseases and disorders
08/12/2008US7410774 Compounds modulating sister chromatid separation and method for identifying same
08/12/2008US7410770 Using collagen specific immunoglobulinsto to identify collagene fragment and diagnose/prognose arthritic disorders; antiarthritis agents
08/12/2008US7410769 Peptide biosensors for anthrax protease
08/12/2008US7410759 Compositions and methods for diagnosing and treating mood disorders
08/12/2008US7410758 Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
08/12/2008US7410757 Expressing nucleic acid in tissue from occipital cortex of brain showing cell death as result of Alzheimer's Disease; isolating suppressor gene
08/12/2008US7410648 Nucleotide sequences coding outer memebrane proteins for use as tools in diagnosis, prevention and treatment of microorganismal infection; immunotherapy; vaccine development
08/12/2008US7410645 Moraxella (Branhamella) catarrhalis antigens
08/12/2008US7410644 Recombinant pox virus for immunization against tumor-associated antigens
08/12/2008US7410642 Assays and therapies for latent viral infection
08/12/2008US7410641 Hybridoma and monoclonal antibodies produced; insulin-like growth factor (IGF); diagnosis, treatment, prevention of diabetes and metabolic disorders
08/12/2008US7410640 Treating hypoxia driven angiogenesis or neovascularization; group B beta hemolytic Streptococcus (GBS)
08/12/2008US7410639 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome
08/12/2008US7410638 Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals
08/12/2008US7410616 Device for the controlled exposure of reservoir-based sensors
08/12/2008CA2354845C Expression system for factor viii
08/12/2008CA2330235C Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders
08/12/2008CA2253238C Novel agouti-related gene
08/12/2008CA2239799C Murine monoclonal anti-idiotype antibody 11d10 and methods of use thereof
08/12/2008CA2135787C Polypeptide bombesin antagonists
08/12/2008CA2131190C Compositions and methods for the treatment of thermal injury
08/09/2008CA2620029A1 Wound healing agent and composition
08/09/2008CA2618099A1 Antagonists of a non-selective cation channel in neural cells
08/07/2008WO2008094969A2 Combination therapy with angiogenesis inhibitors
08/07/2008WO2008094905A2 Encapsulated hdl mimetic peptides
08/07/2008WO2008094708A2 Activin-actriia antagonists and uses for treating or preventing breast cancer
08/07/2008WO2008094275A1 Peptides for treatment of conditions associated with nitric oxide
08/07/2008WO2008094147A1 Immunophilin ligands and methods for modulating immunophilin and calcium channel activity
08/07/2008WO2008094062A1 Pharmaceutical compositions useful for preventing and treating oncological diseases
08/07/2008WO2008094061A1 Pharmaceutical and cosmetic compositions for accelerated healing of wounds and other surface damages
08/07/2008WO2008094037A1 The use of alkaline phosphatase in the treatment of reduced renal function
08/07/2008WO2008093942A1 Methods and compositions for treating motor neuron diseases comprising erythropoietin
08/07/2008WO2008093827A1 Therapeutic agent for central nervous system disorder, and method for treatment of central nervous system disorder
08/07/2008WO2008093756A1 Biological preparation
08/07/2008WO2008093657A1 Skin-beautifying agent
08/07/2008WO2008093646A1 Peptide capable of activating wnt signaling
08/07/2008WO2008093152A1 Obligate heterodimer meganucleases and uses thereof
08/07/2008WO2008093060A2 Peptides and their use
08/07/2008WO2008093059A1 Basic peptides and their use as combined antibacterial-antifungine agents
08/07/2008WO2008093058A2 Peptides and their use
08/07/2008WO2008092894A1 Modulators of sclerostin binding partners for treating bone-related disorders
08/07/2008WO2008092656A1 Use of fibrinogen as a prophylactic treatment to prevent bleeding during and after surgery and as a biomarker to identify patient with an increased risk for excessive bleeding and blood transfusion
08/07/2008WO2008092644A2 Fviii-independent fix-mutant proteins for hemophilia a treatment
08/07/2008WO2008092281A1 Template-fixed peptidomimetics
08/07/2008WO2008092262A1 Methods and compounds for treatment, prevention and diagnosis of parasitic infection and disease
08/07/2008WO2008092209A1 Protein construct with improved properties
08/07/2008WO2008076806A9 Compositions and methods to potentiate colistin activity
08/07/2008WO2008073653A3 Il- 17b for use in wound healing
08/07/2008WO2008070848A3 Method and material for in situ corneal structural augmentation
08/07/2008WO2008069876A3 Amidated dopamine neuron stimulating peptides for cns dopaminergic upregulation
08/07/2008WO2008069012A3 Ejection liquid and ejection method
08/07/2008WO2008060370A3 Method for determining presence of cancer in a sample by assaying for expression of dppa-2 nucleotide sequences
08/07/2008WO2008054585A9 Use of pegylated il-10 to treat cancer
08/07/2008WO2008045252A3 Engineered integrin binding peptides
08/07/2008WO2008034124A3 Targeted polymeric prodrugs containing multifunctional linkers
08/07/2008WO2008027501A3 Laccases for pulp bio-bleaching
08/07/2008WO2008021160A3 Regulation of litaf modulated cytokine production by a novel p53 short peptide